Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Eye Cancer

Protein-expression profiles in mouse blood-plasma following acute whole-body exposure to (137)Cs gamma rays. Int J Radiat Biol. 2009 Apr 7:1–16.
Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 2008 Jun;37(3):654–67.
1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma. J Neurooncol. 2007 Dec;85(3):255–62.
Genetic factors associated with skin cancer in renal transplant patients. Photodermatol Photoimmunol Photomed. 2007 Apr–Jun;23(2–3):62–7. Review.
1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. J Oral Pathol Med. 2006 Sep;35(8):472–8.
Is the current public health message on UV exposure correct? Bull World Health Organ. 2006 Jun;84(6):485–91.
A cell-autonomous requirement for the cell cycle regulatory protein, Rb, in neuronal migration. EMBO J. 2005 Dec 21;24(24):4381–91.
Responsiveness of human retinoblastoma and neuroblastoma models to a non-calcemic 19-nor Vitamin D analog. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):165–72.
The rationale for deltanoids in therapy for myeloid leukemia: role of KSR-MAPK-C/EBP pathway. J Steroid Biochem Mol Biol. 2005 Oct;97(1–2):47–55.
The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol. 2004 Nov;92(4):317–25. Review.
Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models. Arch Ophthalmol. 2004 Sep;122(9):1357–62.
Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model. Arch Ophthalmol. 2004 Sep;122(9):1365–9.
Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells. Cancer Res. 2004 Jan 1;64(1):370–7.
Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4192–9.
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J Biol Chem. 2003 Nov 21;278(47):46862–8.
Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. Biochem Pharmacol. 2003 Aug 1;66(3):495–504.
Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat. 2003 Jul;80(1):49–62.
1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax. Exp Eye Res. 2003 Jul;77(1):1–9.
Effect of 20-epi-1alpha,25-dihydroxyvitamin D3 on the proliferation of human neuroblastoma: role of cell cycle regulators and the Myc-Id2 pathway. Biochem Pharmacol. 2003 Jun 15;65(12):1943–55.
Toxicity and dose-response studies of 1-alpha hydroxyvitamin D2 in LH-beta-tag transgenic mice. Ophthalmology. 2003 Apr;110(4):835–9.
Differentiation of human retinal pigment epithelial cells into neuronal phenotype by N-(4-hydroxyphenyl)retinamide. J Neurochem. 2003 Mar;84(5):972–81.
Derivatives of vitamins D2 and D3 activate three MAPK pathways and upregulate pRb expression in differentiating HL60 cells. Cell Cycle. 2002 Nov–Dec;1(6):410–5.
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. Trans Am Ophthalmol Soc. 2002;100:125–9.
Vitamin D analogs, a new treatment for retinoblastoma: The first Ellsworth Lecture. Ophthalmic Genet. 2002 Sep;23(3):137–56.
Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model. Arch Ophthalmol. 2002 May;120(5):607–12.
Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer. 2002 Mar;9(1):45–59. Review.
Toxicity and dose-response studies of 1 alpha-hydroxyvitamin D2 in LH beta-Tag transgenic mice. Trans Am Ophthalmol Soc. 2002;100:125–9.
Forced expression of the cyclin-dependent kinase inhibitor p16(INK4A) in leukemic U-937 cells reveals dissociation between cell cycle and differentiation. Exp Hematol. 2001 Dec;29(12):1382–91.
1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol. 2001 Jan;121(1):103–9.
Solitary fibrous tumors are immunophenotypically distinct from mesothelioma(s). J Cutan Pathol. 2000 Oct;27(9):451–4.
Elevated cyclin E levels, inactive retinoblastoma protein, and suppression of the p27(KIP1) inhibitor characterize early development of promyeloid cells into macrophages. Mol Cell Biol. 1999 Sep;19(9):6229–39.
Regulation of the mdm2 oncogene by thyroid hormone receptor. Mol Cell Biol. 1999 Jan;19(1):864–72.
Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology. 1998 Mar;139(3):1197–207.
Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Endocrinology. 1997 Nov;138(11):4690–8.
Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat. 1997 Jan;42(1):31–41.
The biomedical effects of ultraviolet radiation and their mechanisms. Usp Fiziol Nauk. 1995 Oct–Dec;26(4):98–112. Review.
Vitamin D inhibits angiogenesis in transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci. 1995 Jan;36(1):83–7.
Vitamin-regulated retinoblastoma tumor suppressor gene expression in leukemic cells. Adv Exp Med Biol. 1994;354:1–18.
The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Invest Ophthalmol Vis Sci. 1992 Jul;33(8):2354–64.
Subtractive cloning of a hybrid human endogenous retrovirus and calbindin gene in the prostate cell line PC3. Cancer Res. 1991 Aug 1;51(15):4107–10.
Chemotherapy in retinoblastoma: current status and future directions. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):189–201. Review.
Further studies of the effect of vitamin D on retinoblastoma. Inhibition with 1,25-dihydroxycholecalciferol. Arch Ophthalmol. 1988 Apr;106(4):541–3.
Verhoeff's query: is vitamin D effective against retinoblastoma? Arch Ophthalmol. 1988 Apr;106(4):536–40.
Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro. Arch Ophthalmol. 1988 Apr;106(4):533–5.
Retinoblastoma undergoing spontaneous regression. Calcifying agent suggested in treatment of retinoblastoma. Am J Ophthalmol. 1966 Sep;62(3):573–4.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.